Drugs / JNJ-17299425
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01814982 | Aug 2007 → Aug 2008 | traumatic brain injury | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-17299425 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01814982 ↗ |
| Route | Intravenous | “as intravenous bolus injection over 2 minutes in central vein” NCT01814982 ↗ |